Digital transformation with My Health Record

Pharmacists should be actively contributing to patients' My Health Record (MHR) in order to unlock the full potential of digital transformation, said Dr Kenneth...

How should chronic pain in children be approached?

There is limited research on the effectiveness of pharmacotherapy in treating in children with chronic pain. So what is the best approach and how...

Pregabalin add-on for drug-resistant focal epilepsy

This evidence summary presents the best available evidence regarding pregabalin add-on for drug-resistant focal epilepsy.1 Introduction Approximately 3–3.5% of Australians will experience epilepsy at some point...

From the President: Pharmacists’ support valued during 2021

'I would like to take this opportunity to thank you for your valued support during 2021,' writes PSA National President A/Prof Chris Freeman.

PSA NT/SA Branch’s vaccine advocacy work

The PSA SA/NT Branch is fighting for pharmacists to be able to administer more vaccines. Read more about it here.

Listings for biosimilar uptake drivers expanded

Amended prescribing information has been released for two biosimilar uptake drivers listed on the Pharmaceutical Benefits Scheme (PBS), as part of the Biosimilar Awareness...